Draft pharmacopoeial changes propose stricter microbial standards for five drug ingredients

The Indian Pharmacopoeia Commission (IPC) has proposed revisions to five pharmacopoeial monographs, introducing bacterial endotoxin limits for three injectable formulations and tighter microbial contamination specifications for two pharmaceutical excipients. The proposed changes aim to strengthen microbiological quality control, enhance patient safety and minimize contamination risks in pharmaceutical products. Once finalized, the revised standards will serve as updated quality requirements for manufacturers and testing laboratories.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.